Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic analyses of lung adenocarcinoma cells

ABSTRACT: Transcriptomic analyses of lung adenocarcinoma cells

PROVIDER: PRJNA843347 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Transcriptomic analyses of lung adenocarcinoma cells and genome-wide maps of chromatin state in lung adenocarcinoma cells

Project description:Transcriptomic analyses of lung adenocarcinoma cells and genome-wide maps of chromatin state in lung adenocarcinoma cells

| PRJNA756032 | ENA

Transcriptomic analyses of lung adenocarcinoma cells

Project description:We investigated the association between genetic variants in the histone modification regions and the prognosis of lung adenocarcinoma after curative surgery. Potentially functional SNPs were selected using integrated analysis of ChIP-seq and RNA-seq. The SNPs were analyzed in a discovery set (n=166) and a validation set (n=238). The associations of the SNPs with overall survival (OS) and disease-free survival (DFS) were analyzed. This study showed that genetic variants in the histone modification regions could predict the prognosis of lung adenocarcinoma after surgery.

2021-08-21 | GSE182383 | GEO

LC/MS-based FFPE tissue-proteomic analyses of early lung adenocarcinoma

Project description:Clinical FFPE tissue proteomic analyses were performed for early lung adenocarcinomas including adenocarcinoma in-situ (AIS), minimally invasive adenocarcinoma (MIA) and lepidic predominant invasive adenocarcinoma (LPA).

2020-01-30 | PXD017334 | JPOST Repository

Transcriptomic profiling of Lung adenocarcinoma brain metastasis

Project description:Transcriptomic profiling of Lung adenocarcinoma brain metastasis

| PRJNA594359 | ENA

LC/MS-based FFPE tissue-proteomic analyses of Japanese lung adenocarcinoma

Project description:lung adenocarcinoma of 36 patients were subjected to LC/MS-based proteomic analyses. Triplicate runs for each sample were performed.

2019-10-17 | PXD015862 | JPOST Repository

Ito2019 - gefitnib resistance of lung adenocarcinoma caused by MET amplification

Project description:The model is based on publication: Mathematical analysis of gefitinib resistance of lung adenocarcinoma caused by MET amplification Abstract: Gefitinib, one of the tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR), is effective for treating lung adenocarcinoma harboring EGFR mutation; but later, most cases acquire a resistance to gefitinib. One of the mechanisms conferring gefitinib resistance to lung adenocarcinoma is the amplification of the MET gene, which is observed in 5–22% of gefitinib-resistant tumors. A previous study suggested that MET amplification could cause gefitinib resistance by driving ErbB3-dependent activation of the PI3K pathway. In this study, we built a mathematical model of gefitinib resistance caused by MET amplification using lung adenocarcinoma HCC827-GR (gefitinib resistant) cells. The molecular reactions involved in gefitinib resistance consisted of dimerization and phosphorylation of three molecules, EGFR, ErbB3, and MET were described by a series of ordinary differential equations. To perform a computer simulation, we quantified each molecule on the cell surface using flow cytometry and estimated unknown parameters by dimensional analysis. Our simulation showed that the number of active ErbB3 molecules is around a hundred-fold smaller than that of active MET molecules. Limited contribution of ErbB3 in gefitinib resistance by MET amplification is also demonstrated using HCC827-GR cells in culture experiments. Our mathematical model provides a quantitative understanding of the molecular reactions underlying drug resistance.

2024-09-02 | BIOMD0000000827 | BioModels

Transcriptomic profiling of oncogenic KRAS and TP53 in lung adenocarcinoma cells

Project description:Transcriptomic profiling of oncogenic KRAS and TP53 in lung adenocarcinoma cells

| PRJNA761664 | ENA

MeRIP-sequencing in lung adenocarcinoma cells

Project description:MeRIP-sequencing in lung adenocarcinoma cells

| PRJNA719778 | ENA

Transcriptomic comparison of FVB mouse strain lung Cells one week upon injecting mice intraperitoneally with urethane and with the mouse lung adenocarcinoma cell line FULA 1

Project description:Transcriptomic comparison of FVB mouse strain lung Cells one week upon injecting mice intraperitoneally with either saline or Urethane. Mouse lung cell were also compared at the transcriptomic level with the mouse lung adenocarcinoma cell line FULA 1, which was established in our lab We injected 6 (3 males, 3 females) FVB mice 8 weeks old, with either saline or urethane. One week later we sacrificed and harvested their lungs. The dissected lungs were assayed to RNA extraction (via trizol) in order to identify their transcriptomic signature. Moreover we compared the gene expression of the mouse lung cells to the mouse lung adenocarcinoma cell line FULA 1.

2018-01-10 | GSE93371 | GEO

Transcriptomic profiling of lung adenocarcinoma associated alleles in A549s

Project description:Transcriptomic profiling of lung adenocarcinoma associated alleles in A549s

| PRJNA855953 | ENA